국소 흉터 치료 시장 규모, 점유율, 동향 분석 : 제품별, 흉터 종류별, 유통 채널·지역별, 부문별 예측(2026-2033년)

Topical Scar Treatment Market Summary

The global topical scar treatment market size was estimated at USD 1,883.3 million in 2025 and is projected to reach USD 4,686.7 million by 2033, growing at a CAGR of 12.1% from 2026 to 2033. The market is expected to grow due to several factors, such as the growing concern among people regarding their aesthetic appearance, the increasing number of road accidents and burn injuries, and technological advancements supplementing new device launches.

According to a 2024 review published in the Journal of Clinical and Aesthetic Dermatology (2024) by Andrew Alexis et al., acne affects approximately 9.4% of the global population and remains one of the most common dermatologic conditions worldwide. While historically considered an adolescent disorder, adult acne is increasingly recognized, expanding the long-term treatment population.

Importantly, acne frequently results in post-inflammatory hyperpigmentation (PIH), atrophic scars, and hypertrophic or keloid scars, conditions that often persist long after active lesions resolve. These sequelae are particularly prevalent in individuals with skin of color (SOC), who exhibit higher melanocyte reactivity and an increased risk of pigmentary alterations. Studies cited in the review report PIH in 65% of African American women and 48% of Hispanic women, compared to 10-25% in lighter phototypes. In some African cohorts, acne scarring was observed in up to 87.5% of adult women, even when acne severity was mild to moderate.

Topical products refer to various substances, compounds, or formulations that are applied to the surface of the skin, hair, or nails for various purposes. These products are designed to have localized effects on the area of application and are commonly used in skincare, haircare, and other personal care routines. A model was developed by analyzing the prevalence of scars across regions and countries. It was seen that most of the patients sought topical treatment for scar management. The adoption rates of creams, gels, silicon sheets, and other products were then analyzed. In addition, average product prices, usability, and treatment duration were considered for determining the market size and assigning the segment split for each product type.

In February 2024, a landmark global epidemiology study was published in the Journal of the American Academy of Dermatology (JAAD) by Pierre Fabre Laboratories under the ALL-project initiative. This large-scale study surveyed 50,552 adults across 20 countries, representing over 50% of the world's population, making it one of the most comprehensive assessments of acne prevalence and its societal impact. The study found that global acne prevalence stands at 20.5%, meaning one in five individuals worldwide is affected. Prevalence is highest among adolescents and young adults (16-24 years) at 28.3% and remains high in adults aged 25-39 years at 19.3%. Women are more affected than men (23.6% vs. 17.5%), broadening the long-term consumer base for post-acne scar and pigmentation treatments.

Advancements in technology and innovation are driving the growth of the topical scar treatment industry, with a strong focus on natural-based treatments and multifunctional products. Innovations have led to the development of effective, gentle formulations that incorporate natural ingredients such as aloe vera, onion extract, vitamin E, and centella asiatica (often known as "cica"), which are well-known for their scar-reducing and skin-soothing properties. For instance, in September 2024, Dr. Speron's Natural Skin Care, LLC, introduced an innovative product designed to make a meaningful difference for individuals dealing with the physical and emotional impact of scars from injuries, surgeries, and skin conditions. These natural-based treatments appeal to consumers seeking safe, skin-friendly options with fewer synthetic chemicals.treatment products are also extensively used.

Global Topical Scar Treatment Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global topical scar treatment market report based on product, scar type, distribution channel, and region:

• Product Outlook (Volume, Units; Revenue, USD Million, 2021 - 2033)
• Creams
• Gels
• Silicon Sheets
• Others
• Scar Type Outlook (Revenue, USD Million, 2021 - 2033)
• Atrophic Scars
• Hypertrophic & Keloid Scars
• Contracture Scars
• Stretch Marks
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Hospital Pharmacies
• Retail Pharmacies
• Online
• Hypermarkets/ Supermarkets
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Spain
  • France
  • Italy
  • Denmark
  • Norway
  • Sweden
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Scar Type
  • 1.2.3. Distribution Channel
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Scar type outlook
  • 2.2.3. Distribution channel outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Topical Scar Treatment Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing demand for aesthetics
    • 3.2.1.2. Growing number of road accidents and burn cases
    • 3.2.1.3. Growing technological advancements
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Limited effectiveness for severe scars
    • 3.2.2.2. Consumer skepticism and slow adoption
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Growing awareness of skincare and personal appearance
    • 3.2.3.2. Growing popularity of e-commerce
• 3.3. Topical Scar Treatment Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Environmental landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Global Topical Scar Treatment Market: Product Estimates & Trend Analysis

• 4.1. Topical Scar Treatment Market: Product Dashboard
• 4.2. Topical Scar Treatment Market: Product Movement Analysis
• 4.3. Topical Scar Treatment Market Size & Forecasts and Trend Analyses, 2021 to 2033
• 4.4. Creams
  • 4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million, Volume Units)
• 4.5. Gels
  • 4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million, Volume Units)
• 4.6. Silicon Sheets
  • 4.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million, Volume Units)
• 4.7. Others
  • 4.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million, Volume Units)

Chapter 5. Global Topical Scar Treatment Market: Scar Type Estimates & Trend Analysis

• 5.1. Topical Scar Treatment Market: Scar Type Dashboard
• 5.2. Topical Scar Treatment Market: Scar Type Movement Analysis
• 5.3. Topical Scar Treatment Market Size & Forecasts and Trend Analyses, 2021 to 2033
• 5.4. Atrophic Scars
  • 5.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Hypertrophic and Keloid Scars
  • 5.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. Contracture Scars
  • 5.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.7. Stretch Marks
  • 5.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Global Topical Scar Treatment Market: Distribution Channel Estimates & Trend Analysis

• 6.1. Topical Scar Treatment Market: Distribution Channel Dashboard
• 6.2. Topical Scar Treatment Market: Distribution Channel Movement Analysis
• 6.3. Topical Scar Treatment Market Size & Forecasts and Trend Analyses, 2021 to 2033
• 6.4. Hospital Pharmacies
  • 6.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Retail Pharmacies
  • 6.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Online
  • 6.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.7. Hypermarkets/ Supermarkets
  • 6.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Regional Estimates & Trend Analysis by Product, Scar Type, Distribution Channel

• 7.1. Global Topical Scar Treatment Market: Regional Dashboard
• 7.2. Global Topical Scar Treatment Market: Regional Movement Analysis
• 7.3. Global Topical Scar Treatment Market Size & Forecasts and Trend Analyses by Product, Scar Type, Distribution Channel, 2021 to 2033
• 7.4. North America
  • 7.4.1. U.S.
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. Canada
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. Mexico
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Europe
  • 7.5.1. Germany
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Spain
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Denmark
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Sweden
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework/ reimbursement structure
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5.8. Norway
    • 7.5.8.1. Key country dynamics
    • 7.5.8.2. Regulatory framework/ reimbursement structure
    • 7.5.8.3. Competitive scenario
    • 7.5.8.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. China
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. India
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. Japan
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.4. South Korea
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework/ reimbursement structure
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework/ reimbursement structure
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework/ reimbursement structure
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. Latin America
  • 7.7.1. Brazil
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. Argentina
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.8. MEA
  • 7.8.1. South Africa
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework/ reimbursement structure
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.8.2. Saudi Arabia
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework/ reimbursement structure
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.8.3. UAE
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework/ reimbursement structure
    • 7.8.3.3. Competitive scenario
    • 7.8.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.8.4. Kuwait
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Regulatory framework/ reimbursement structure
    • 7.8.4.3. Competitive scenario
    • 7.8.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2025
  • 8.3.4. Smith & Nephew
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Merz North America, Inc.
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. LUMENIS
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Enaltus LLC
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Sonoma Pharmaceuticals, Inc.
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Molnlycke Health Care
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Cynosure, Inc.
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. CCA Industries, Inc.
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Scar Heal Inc.
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. NewMedical Technology
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. Suneva Medical Inc.
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives
  • 8.3.15. Pacific World Corporation
    • 8.3.15.1. Company overview
    • 8.3.15.2. Financial performance
    • 8.3.15.3. Product benchmarking
    • 8.3.15.4. Strategic initiatives
  • 8.3.16. Perrigo Company plc
    • 8.3.16.1. Company overview
    • 8.3.16.2. Financial performance
    • 8.3.16.3. Product benchmarking
    • 8.3.16.4. Strategic initiatives